TNPSC Thervupettagam

Needle-free COVID-19 vaccine

September 27 , 2024 57 days 139 0
  • The India-Australia collaboration has developed a needle-free intra-nasal booster vaccine against SARS-CoV-2.
  • This live-attenuated booster has been developed using ‘codon de- optimisation’ technology.
  • Codon de-optimisation involves decreasing the frequency of under-represented codon pairs (genetic determinants for amino acids) without changing the amino acid sequences.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories